OBJECTIVE: To test the hypothesis that bladder cancer is a heterogeneous disease. PATIENTS AND METHODS: We examined the temporal trends of bladder cancer by histological subtype and by disease stage and grade using the National Cancer Institute's Surveillance, Epidemiology, and End Results data collected in 1973-2007. RESULTS: The age-adjusted incidence rates of bladder cancer showed a slight decrease from 1973 to 2007 (annual percentage change [APC] = -0.4, P < 0.05). Although the age-adjusted incidence rates of non-papillary transitional cell carcinoma decreased by about 53% from 7.9 per 100,000 in 1973 to 3.7 per 100,000 in 2007 (APC = -2.2, P < 0.05), the age-adjusted incidence rates of papillary transitional cell carcinoma increased by about 56% from 6.8 per 100,000 in 1973 to 10.6 per 100,000 in 2007 (APC = 0.5, P < 0.05). Among other rare histological subtypes, except for small cell carcinoma which showed a slightly rising trend, squamous cell carcinoma, adenocarcinoma and others all presented a decreasing trend. Similar patterns were found for different stages (localized, regional and distant), but a dramatic increasing trend of grade IV was found between 1998 and 2007 when a corresponding decreasing trend was shown for grades I, II and III. CONCLUSION: The results support the hypothesis that bladder cancer is a heterogeneous disease and taking disease heterogeneity into consideration in future epidemiological studies is essential.
OBJECTIVE: To test the hypothesis that bladder cancer is a heterogeneous disease. PATIENTS AND METHODS: We examined the temporal trends of bladder cancer by histological subtype and by disease stage and grade using the National Cancer Institute's Surveillance, Epidemiology, and End Results data collected in 1973-2007. RESULTS: The age-adjusted incidence rates of bladder cancer showed a slight decrease from 1973 to 2007 (annual percentage change [APC] = -0.4, P < 0.05). Although the age-adjusted incidence rates of non-papillary transitional cell carcinoma decreased by about 53% from 7.9 per 100,000 in 1973 to 3.7 per 100,000 in 2007 (APC = -2.2, P < 0.05), the age-adjusted incidence rates of papillary transitional cell carcinoma increased by about 56% from 6.8 per 100,000 in 1973 to 10.6 per 100,000 in 2007 (APC = 0.5, P < 0.05). Among other rare histological subtypes, except for small cell carcinoma which showed a slightly rising trend, squamous cell carcinoma, adenocarcinoma and others all presented a decreasing trend. Similar patterns were found for different stages (localized, regional and distant), but a dramatic increasing trend of grade IV was found between 1998 and 2007 when a corresponding decreasing trend was shown for grades I, II and III. CONCLUSION: The results support the hypothesis that bladder cancer is a heterogeneous disease and taking disease heterogeneity into consideration in future epidemiological studies is essential.
Authors: Dominique S Michaud; Margaret E Wright; Kenneth P Cantor; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes Journal: Am J Epidemiol Date: 2004-11-01 Impact factor: 4.897
Authors: Hiroshi Miyamoto; Jeremy S Miller; Daniel A Fajardo; Thomas K Lee; George J Netto; Jonathan I Epstein Journal: Pathol Int Date: 2010-01 Impact factor: 2.534
Authors: Michael N Bates; Omar A Rey; Mary L Biggs; Claudia Hopenhayn; Lee E Moore; David Kalman; Craig Steinmaus; Allan H Smith Journal: Am J Epidemiol Date: 2004-02-15 Impact factor: 4.897
Authors: Kristina M Jordahl; Amanda I Phipps; Timothy W Randolph; Hilary A Tindle; Simin Liu; Lesley F Tinker; Karl T Kelsey; Emily White; Parveen Bhatti Journal: Epigenetics Date: 2019-06-23 Impact factor: 4.528
Authors: Kristina M Jordahl; Timothy W Randolph; Xiaoling Song; Cassandra L Sather; Lesley F Tinker; Amanda I Phipps; Karl T Kelsey; Emily White; Parveen Bhatti Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-03-14 Impact factor: 4.254
Authors: Damiano Fantini; Alexander P Glaser; Kalen J Rimar; Yiduo Wang; Matthew Schipma; Nobish Varghese; Alfred Rademaker; Amir Behdad; Aparna Yellapa; Yanni Yu; Christie Ching-Lin Sze; Lu Wang; Zibo Zhao; Susan E Crawford; Deqing Hu; Jonathan D Licht; Clayton K Collings; Elizabeth Bartom; Dan Theodorescu; Ali Shilatifard; Joshua J Meeks Journal: Oncogene Date: 2018-01-25 Impact factor: 9.867
Authors: Joseph R Podojil; Alexander P Glaser; Dylan Baker; Elise T Courtois; Damiano Fantini; Yanni Yu; Valerie Eaton; Santhosh Sivajothi; Mingyi Chiang; Arighno Das; Kimberly A McLaughlin; Paul Robson; Stephen D Miller; Joshua J Meeks Journal: Oncoimmunology Date: 2020-04-16 Impact factor: 8.110